Actively Recruiting
Phase 2 Study of Intravenous Calcium Gluconate to Prevent Blood Loss During Cesarean Delivery in Pregnant Women at High Risk for Uterine Atony
Led by University of Michigan · Updated on 2026-07-24
140
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying pregnant women at high risk for uterine atony to find out how a single dose of intravenous calcium gluconate affects blood loss during cesarean delivery. The study is a Phase 2 randomized trial comparing calcium gluconate to a placebo to prevent excessive bleeding during surgery. This research is FDA IND exempt and aims to improve outcomes in cesarean deliveries with high bleeding risk. Participants are randomly assigned to receive either a slow push intravenous dose of 2 grams of calcium gluconate diluted in normal saline or a placebo of 75 mL intravenous saline. The study focuses on delivering the intervention during cesarean delivery to assess its impact immediately and shortly after surgery. Two groups are compared in parallel to evaluate the prevention of blood loss. During the study, participants will be monitored closely for blood loss at delivery and up to four hours after surgery. Additional assessments include transfusion needs, changes in hematocrit and hemoglobin levels, uterotonic medication use, intensive care admissions, and additional procedures within 48 hours. The primary outcome is quantitative blood loss measured immediately after surgery. The total study duration extends until 48 hours post-delivery to monitor safety and treatment effects.
CONDITIONS
Brief Title
Prophylactic Intravenous Calcium Gluconate to Decrease Blood Loss at Time of Cesarean Delivery in Pregnant Patients at High Risk for Uterine Atony
Research Team
A
AnneMarie Opipari, MD
H
Hero Eisley
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here